Thyroid function test abnormalities in treatment-resistant schizophrenia
Ertac Orsel, Atila Erol, Hilal Kapudan, Semra Karayilan, Mustafa Ozten
( Psychiatry and Clinical Psychopharmacology 2015; 25: S179-S179)
Psychiatry and Clinical Psychopharmacology
Psychiatry and Clinical Psychopharmacology
PDF
.jpg)
HIGHLY CITED ARTICLES
High Doses of Second-Generation Long-Acting Antipsychotics in the Treatment of Patients with Severe Resistant Schizophrenia: A Six-Year Mirror-Image Study
by Fernandez- Miranda et al.
Parental Attachment and the Theory of Mind Abilities as Predictors of Internet Addiction in Turkish Adolescents
by Akdeniz et al.
Adaptation of Internet Gaming Cognition Scale to Turkish: Reliability and Validity Study
by Cakiroglu and Soylu.
.png)
- Home
- Search
Search Results
Total of 29 results
Adjunctive quetiapine may help fluvoxamine-resistant obsessive-compulsive disorder among female in-patients: A randomized-controlled study
Saeed Shoja Shafti, Hamid Kaviani
( Psychiatry and Clinical Psychopharmacology 2019; 29: 171-177) DOI: 10.1080/24750573.2019.1597584
The impact of high-frequency repetitive transcranial magnetic stimulation on executive functioning of drug-free patients with treatment-resistant depression
Celal Şalçini, Gökben Hızlı, Merve Çebi, Oğuz Tan, Gaye Kağan, Oğuz Tanrıdağ, Nevzat Tarhan
( Psychiatry and Clinical Psychopharmacology 2018; 28: 185-190) DOI: 10.1080/24750573.2017.1421398
Differential effects of clozapine and risperidone on facial emotion recognition ability in patients with treatment-resistant schizophrenia
Gozde Gultekin, Erhan Yuksek, Tevfik Kalelioglu, Alper Bas, Tuba Bas, Alaattin Duran
( Psychiatry and Clinical Psychopharmacology 2017; 27: 19-23) DOI: 10.1080/24750573.2017.1293242
Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study
( Psychiatry and Clinical Psychopharmacology 2017; 27: 235-242) DOI: 10.1080/24750573.2017.1342753
Drug Abuse of Modafinil by a Cannabis User
( Psychiatry and Clinical Psychopharmacology 2014; 24: 405-407) DOI: 10.5455/bcp.20130624013303
Stalking in an erotomanic patient diagnosed as resistant depression: a case report
( Psychiatry and Clinical Psychopharmacology 2014; 24: S165-S165)
Evaluation of the efficacy of the continuation electroconvulsive therapy in treatment-resistant schizophrenia
( Psychiatry and Clinical Psychopharmacology 2014; 24: S117-S117)
Pharmacokinetics solutions in patients with treatment-resistant, CYP enzyme systems, fast and slow metabolizer
( Psychiatry and Clinical Psychopharmacology 2014; 24: S29-S29)
Treatment resistant patient and personalized medicine
( Psychiatry and Clinical Psychopharmacology 2014; 24: S18-S18)
Unmet needs in psychiatry and emerging novel pharmacological agents
( Psychiatry and Clinical Psychopharmacology 2013; 23: 199-204) DOI: 10.5455/bcp.20130927064824
Mirtazapine combination in treatmentresistant major depressive disorder: a retrospective evaluation of six weeks
Omer Aydemir, Artuner Deveci, E.Oryal Taskin
( Psychiatry and Clinical Psychopharmacology 2009; 19: 347-352)
The etiology and treatment of clozapine induced sialorrhoea
Defne Eraslan, Özgür Öztürk, Yasin Genç, Ayhan Kalyoncu
( Psychiatry and Clinical Psychopharmacology 2007; 17: 147-154)
Olanzapine augmentation in elderly patients with treatment-resistant major depression: an open trial
Hasan Mırsal, Ayhan Kalyoncu, Özkan Pektaş, Devran Tan, Mansur Beyazyürek
( Psychiatry and Clinical Psychopharmacology 2003; 13: 1-5)
An Overview of The Definition and Management of Treatment-Resistant Depression
Diane Bird, Peter M. Haddad, Serdar M. Dursun
( Psychiatry and Clinical Psychopharmacology 2002; 12: 92-101)
CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENIA: FOLLOWED-UP STUDY FOR THREE YEARS
Aytekin Özşahin, Özcan Uzun, Nahit Özmenler, Ali Doruk, Salih Battal
( Psychiatry and Clinical Psychopharmacology 2000; 10: 74-80)
THE EFFICACY OF CLOZAPINE IN A GROUP TREATMENT-RESİSTANT SCHIZOPHRENIC PATIENTS
Cengiz SOYLU, Mustafa BİLİCİ, Mehmet Bekaroğlu, Fatma YILDIRIM
( Psychiatry and Clinical Psychopharmacology 1999; 9: 34-38)
TREATMENT RESISTANT DEPRESSION
( Psychiatry and Clinical Psychopharmacology 1999; 9: 68-77)
A COMPARISON OF EFFICACY AND SAFETY OF CLOZAPINE AND SULPIRIDE IN TREATMENT-RESISTANT SCHIZOPHRENIA
Hasan Herken, Nazmiye Kaya, Lütfullah Beşiroğlu, Hüdaverdi Derman, İshak Özkan
( Psychiatry and Clinical Psychopharmacology 1999; 9: 148-151)
CLOZAPINE USE IN CASE WITH TREATMENT RESİSTANT CATATONIC SCHIZOPHRENIA AND TARDIVE DYSKINESIA
( Psychiatry and Clinical Psychopharmacology 1998; 8: 40-42)
EFFICACY AND SAFETY OF SULPIRIDE IN TREATMENT-RESISTANT PSYCHOSIS
Mesut ÇETlN, Ahmet ÖZÇUBUKÇUOĞLU, Cengiz BAŞOĞLU, Ümit Semiz, Mehmet FİLİZ
( Psychiatry and Clinical Psychopharmacology 1998; 8: 18-24)
EFFICACY OF CLOZAPINE IN TREATM ENT-RESISTANT SCHIZO PHRENIA AND THE RELATIO SHIP W ITH DEMOGRA PHIC AND CLINICAL PARAM ETERS
Aytekin Özşahin, Özcan Uzun, Ali Doruk
( Psychiatry and Clinical Psychopharmacology 1998; 8: 14-17)
Clinical psychiatry ECT treatment during the manic episode a treatment-resistant patient with bipolar disorder and comorbid epilepsy
( Psychiatry and Clinical Psychopharmacology 2013; 23: S208-S209)
Psychopharmacology Efficacy of clozapine in treatment-resistant schizophrenia
( Psychiatry and Clinical Psychopharmacology 2013; 23: S80-S81)
N-Acethyl cystein in treatment resistant schizophrenia: Remission and relaps
Feridun Bülbül, İhsan Aksoy, Gokay Alpak, Osman Virit, Haluk Savas
( Psychiatry and Clinical Psychopharmacology 2012; 22: S133-S133)
Addition of aripiprazole to the clozapine: A case report
Meltem Puşuroğlu, Selim Polat, Fatmagül Helvacı, Gökhan Kandemir, Bülent Bahçeci, Çiçek Hocaoğlu
( Psychiatry and Clinical Psychopharmacology 2012; 22: S119-S119)
Efficacy and 3-month follow-up of repetitive transcranial magnetic stimulation (rTMS) in treatment resistant depression: Three cases
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)
Treatment strategies for treatment resistant depression
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)
Copper and Impulsivity in Ketamine Treatment for Treatment-Resistant Mood Disorders
Jakub Słupski, Wiesław Jerzy Cubała, Natalia Górska, Anita Słupska, Maria Gałuszko-Węgielnik
( Psychiatry and Clinical Psychopharmacology 2021; 31: 353-357) DOI: 10.5152/pcp.2021.21949